CareCloud Inc. sell geldnutzer
Start price
10.07.21
/
50%
€6.85
Target price
10.07.22
€3.20
Performance (%)
-46.86%
End price
11.07.22
€3.64
Summary
This prediction ended on 11.07.22 with a price of €3.64. The SELL prediction by geldnutzer for CareCloud Inc. performed very well with a performance of -46.86%. geldnutzer has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
CareCloud Inc. | -6.154% | -6.154% | -65.602% |
iShares Core DAX® | 3.178% | 0.980% | 15.331% |
iShares Nasdaq 100 | 2.972% | 0.925% | 39.831% |
iShares Nikkei 225® | 0.545% | -4.556% | 17.661% |
iShares S&P 500 | 2.367% | 0.833% | 30.000% |
According to geldnutzer what are the pros and cons of CareCloud Inc. for the foreseeable future?
Pros
Cons
Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Few uniques
Dependend from some customers or products
Little known brand
Sustainability is little important
high free float
Higher risks for its business
Business model of the past or high risk
Bad culture
Probably not worthwhile Investment
Little innovation
Significant cyclical dependencies
Comments by geldnutzer for this prediction
In the thread MTBC Inc. diskutieren
Sell mit Kursziel 5,5
Kursziel geändert auf 6,5
Kursziel geändert auf 5,5
Kursziel geändert auf 4,5
Kursziel geändert auf 3,5
Kursziel geändert auf 3,2
In the thread Trading CareCloud Inc.
Die von geldnutzer gewählte maximale Laufzeit wurde überschritten
Stopped prediction by geldnutzer for CareCloud Inc.
CareCloud Inc.
Start price
Target price
Perf. (%)
€7.30
12.06.21
12.06.21
€8.50
12.06.22
12.06.22
-6.16%
10.07.21
10.07.21
Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected